March 27th 2024
Joseph Mikhael, MD, discusses unmet needs that remain to be addressed in the treatment of patients with multiple myeloma.
February 15th 2024
Joseph Mikhael, MD, discusses treatment advancements and ongoing research in multiple myeloma.
February 7th 2024
Joseph Mikhael, MD, discusses the utility of isatuximab, carfilzomib, lenalidomide, and dexamethasone in patients with newly diagnosed multiple myeloma.
February 6th 2024
Joseph Mikhael, MD, discusses the importance of researching disparities in treatment outcomes for patients with multiple myeloma.
February 4th 2024
Joseph Mikhael, MD, discusses the importance of closing gaps in care for patients with multiple myeloma in underserved populations.
January 12th 2023
Dr Joseph Mikhael and expert panel re-visit the patient case and offer their final thoughts on the impact of clinical trial updates in the treatment landscape of multiple myeloma.
Dr Joseph Mikhael and expert panel discuss key efficacy and safety outcomes of pivotal clinical trials evaluating treatment regimens in patients with R/R multiple myeloma.
January 5th 2023
Dr Joseph Mikhael and expert panel review current treatment options for patients with early relapse multiple myeloma, in accordance with current NCCN guidelines.
Dr Joseph Mikhael and expert panel review a case study in early relapse multiple myeloma and the impact of cytogenetics in risk assessment for patients with early relapse multiple myeloma.
December 22nd 2022
Joseph Mikhael, MD, discusses diagnosis criteria and treatment considerations for patients with multiple myeloma in the frontline setting.
November 4th 2022
Joseph Mikhael, MD, and Craig Cole, MD, close the program by sharing examples of times culturally competent care was paramount to the treatment of their patients.
October 28th 2022
Expert panelists share their closing thoughts on the path to improve health equity in multiple myeloma management for racial and ethnic minority groups.
October 27th 2022
Craig Cole, MD, shares advice for community physicians on providing culturally competent care to patients with multiple myeloma that embraces their beliefs, spiritualities, and ethnicities.
A key opinion leader lists the factors that affect access to quality care for Black Americans with multiple myeloma.
October 21st 2022
Joint consideration for physician bias in the management of multiple myeloma and how it can be addressed while treating patients belonging to racial and ethnic minority groups.
Centering discussion clinical trials in multiple myeloma, panelists review how to improve access to these studies for racial and ethnic minority groups.
October 20th 2022
An expert discusses the stigmas behind clinical trials and the shockingly low rate of enrollment by Black Americans with multiple myeloma.
Dr Craig Cole explains why awareness about multiple myeloma needs to be raised in Black American communities by healthcare workers.
October 14th 2022
Experts on multiple myeloma share comprehensive insight on how to build better access to specialty care for patients of racial and ethnic minority groups.
Expert perspectives on how to improve the early detection of multiple myeloma within patients belonging to racial and ethnic minority groups.